Acute Effects of Statin Therapy on Coronary Atherosclerosis Following an Acute Coronary Syndrome

American Journal of Cardiology

Volumn 104, Issue 6, 2009, Pages 750-757

  Rodés Cabau, Josep ^a   Tardif, Jean Claude ^b   Cossette, Mariève ^b   Bertrand, Olivier F ^a   Ibrahim, Reda ^b   Larose, Eric ^a   Grégoire, Jean ^b   L'Allier, Philippe L ^b   Guertin, Marie Claude ^b  

^a LAVAL UNIVERSITY   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN ANTAGONIST; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CHOLESTEROL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EZETIMIBE; FIBRIC ACID DERIVATIVE; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PLACEBO; PRAVASTATIN; RECONSTITUTED HIGH DENSITY LIPOPROTEIN; ROSUVASTATIN; SIMVASTATIN; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROMA; ATHEROSCLEROTIC PLAQUE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; FOLLOW UP; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ACUTE CORONARY SYNDROME; AGED; ANTICHOLESTEREMIC AGENTS; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; FEMALE; HEPTANOIC ACIDS; HUMANS; MALE; MIDDLE AGED; PYRROLES; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 69449104984     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.05.009     Document Type: Article

References (19)

1. Cannon C.P., Braunwauld E., McCabe C.H., Rader D.J., Rouleau J.L., Belder R., Joyal S.V., Hill K.A., Pfeffer M.A., and Skene A.M. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350 (2004) 1495-1504
2. Schwartz G.G., Olsson A.G., Ezekowitz M.D., Ganz P., Oliver M.F., Waters D., Zeiher A., Chaitman B.R., Leslie S., and Stern T. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study; a randomized controlled trial. JAMA 285 (2001) 1711-1718
3. Stenestrand U., and Wallentin L. Early statin treatment following acute myocardial infarction and 1-year survival. JAMA 285 (2001) 430-436
4. Aronow H.D., Topol E.J., Roe M.T., Houghtaling P.L., Wolski K.E., Lincoff A.M., Harrington R.A., Califf R.M., Ohman E.M., Kleiman N.S., Keltai M., Wilcox R.G., Vahanian A., Armstrong P.W., and Lauer M.S. Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study. Lancet 357 (2001) 1063-1068
5. Guédès A., and Tardif J.C. Intravascular ultrasound assessment of atherosclerosis. Curr Atheroscler Rep 6 (2004) 219-224
6. Nicholls S.J., Sipahi I., Schoenhagen P., Crowe T., Tuzcu E.M., and Nissen S.E. Application of intravascular ultrasound in anti-atherosclerotic drug development. Nat Rev Drug Discov 5 (2006) 485-492
7. Jensen L.O., Thayssen P., Pedersen K.E., Stender S., and Haghfelt T. Regression of coronary atherosclerosis by simvastatin. A serial intravascular ultrasound study. Circulation 110 (2004) 265-270
8. Nissen S.E., Nicholls S.J., Sipahi I., Libby P., Raichlen J.S., Ballantyne C.M., Davignon J., Erbel R., Fruchart J.C., Tardif J.C., Schoenhagen P., Crowe T., Cain V., Wolski K., Goormastic M., and Tuzcu E.M. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis. The ASTEROID trial. JAMA 295 (2006) 1556-1565
9. Nissen S.E., Tuzcu E.M., Schoenhagen P., Brown B.G., Ganz P., Vogel R.A., Crowe T., Howard G., Cooper C.J., Brodie B., Grines C.L., and DeMaria A.N. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis. A randomized controlled trial. JAMA 291 (2004) 1071-1080
10. Tardif J.C., Grégoire J., L'Allier P., Ibrahim R., Lespérance J., Heinonen T.M., Kouz S., Berry C., Basser R., Lavoie M.A., Guertin M.C., and Rodés-Cabau J. Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis. A randomized controlled trial. JAMA 297 (2007) 1675-1682
11. Okazaki S., Yokoyama T., Miyauchi K., Shimada K., Kurata T., Sato H., and Daida H. Early statin treatment in patients with acute coronary syndrome. Demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study. Circulation 110 (2004) 1061-1068
12. Ray K.K., Cannon C.P., McCabe C.H., Cairns R., Tonkin A.M., Sacks F.M., Jackson G., and Braunwald E. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 46 (2005) 1405-1410
13. Ray K.K., and Cannon C.P. Early time to benefit with intensive statin treatment: could it be the pleiotropic effects?. Am J Cardiol 96 suppl 5A (2005) 54F-60F
14. Wiviott S.D., de Lemos J.A., Cannon C.P., Blazing M., Murphy S.A., McCabe C.H., Califf R., and Braunwald E. A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22. Circulation 113 (2006) 1406-1414
15. Nissen S.E., Tuzcu E.M., Schoenhagen P., Crowe T., Sasiela W.J., Tsai J., Orazem J., Magorien R.D., O'Shaughnessy C., and Ganz P. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 352 (2005) 29-38
16. Nicholls S.J., Tuzcu E.M., Sipahi I., Grasso A.W., Schoenhagen P., Hu T., Wolski K., Growe T., Desai M.Y., Hazen S.L., Kapadia S.R., and Nissen S.E. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA 297 (2007) 499-508
17. Lemieux I., Lamarche B., Couillard C., Pascot A., Cantin B., Bergeron J., Dagenais G.R., and Després J.P. Total cholesterol/HDL cholesterol ratio vs. LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. Arch Intern Med 161 (2001) 2685-2692
18. Jeppesen J., Hein H.O., Suadicani P., and Gyntelberg F. Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study. Arterioscler Thromb Vasc Biol 17 (1997) 1114-1120
19. Bogaty P., Boyer L., Simard S., Dauwe F., Dupuis R., Verret B., Huynh T., Bertrand F., Dagenais G.R., and Brophy J.M. Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (Recurrence and Inflammation in the Acute Coronary Syndromes) study. J Am Coll Cardiol 51 (2008) 2339-2346